Bavarian Nordic
Biopharmaceutical company developing cancer immunotherapies and vaccines against infectious diseases. Learn more
Launch date
Employees
Market cap
AUD4.3b
Enterprise valuation
AUD3.8b (Public information from Sep 2024)
Share price
€33.05 BV3.F
Company register number 16271187
Hellerup Capital Region of Denmark (HQ)
Authorizing premium user...